RMRamiro Malgor

Ramiro Malgor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ramiro Malgor has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Mitchell J. Silver

    Midwest Cardiology Research Foundation, Columbus, Ohio, USA

    4 shared publications
  • Douglas J. Goetz

    Department of Chemical and Biomolecular Engineering, Biomedical Engineering Program, Ohio University, Athens, USA

    3 shared publications
  • Ian Ackers

    Heritage Fellow, Translational Biomedical Sciences Program, Ohio University, Athens, Ohio, USA

    3 shared publications
  • Kelly D. McCall

    Department of Specialty Medicine, Appalachian Rural Health Institute, Diabetes Research Center, College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA

    3 shared publications
  • Pooja M. Bhatt

    Department of Biological Sciences, Molecular and Cellular Biology Graduate Program, Ohio University, Athens, OH, USA

    3 shared publications
  • Christopher J. Lewis

    Department of Biological Sciences, Molecular and Cellular Biology Graduate Program, Ohio University, Athens, Ohio

    2 shared publications

Latest Publications

  • Differential expression of WNT5A long and short isoforms in non-muscle-invasive bladder urothelial carcinoma

    by Amy M. Strope, Cody Phillips, Sabin Khadgi, Scott A. Jenkinson, Karen T. Coschigano, Ramiro Malgor

    Wnt ligands belong to a family of secreted glycoproteins in which binding to a range of receptors/co-receptors activates several intracellular pathways. WNT5A, a member of the Wnt family, is classified as a non-canonical Wnt whose activation triggers planar cell polarity (PCP) and Ca +2 downstream pathways. Aberrant expression of WNT5A has been shown to play both protective and harmful roles in an array of conditions, such as inflammatory disease and cancer. In the present study, using histological, immunohistochemical, and molecular methods, we investigated the expression of two isoforms of WNT5A, WNT5A-Short (WNT5A-S) and WNT5A-Long (WNT5A-L) in bladder urothelial carcinoma (UC). Three UC cell lines (RT4, J82, and T24), as well as a normal urothelial cell line, and formalin -fixed, paraffin-embedded (FFPE) transurethral resection (TUR) tissue samples from 17 patients diagnosed with UC were included in the study. WNT5A-L was the predominantly expressed isoform in urothelial cells, although WNT5A-S was also detectable. Further, although no statistically significant difference was found between the percentage of WNT5A-S transcripts in low-grade versus high-grade tumors, we did find a difference between the percentage of WNT5A-S transcripts found in non -invasion versus invasion of the lamina propria, subgroups of non-muscle-invasive tumors. In conclusion, both WNT5A-S and WNT5A-L isoforms are expressed in UC, and the percentage of their expression levels suggests that a higher proportion of WNT5A-S transcription may be associated with lamina propria invasion, a process preceding muscle invasion.


  • Open Access

    Consequences of Both Coxsackievirus B4 and Type 1 Diabetes on Female Non-Obese Diabetic Mouse Kidneys

    by Debra L. Walter, Jean R. Thuma, Ramiro Malgor, Frank L. Schwartz, Kelly D. McCall, Karen T. Coschigano

    Despite the 2019 Executive Order on Advancing American Kidney Health Initiative, kidney disease has moved up in rank from the 9th to the 8th leading cause of death in the United States. A recent push in the field of nephrology has been to identify molecular markers and/or molecular profiles involved in kidney disease process or injury that can help identify the cause of injury and predict patient outcomes. While these studies have had moderate success, they have not yet considered that many of the health conditions that cause kidney disease (diabetes, hypertension, etc.) can also be caused by environmental factors (such as viruses), which in and of themselves can cause kidney disease. Thus, the goal of this study was to identify molecular and phenotypic profiles that can differentiate kidney injury caused by diabetes (a health condition resulting in kidney disease) and coxsackievirus B4 (CVB4) exposure (which can cause diabetes and/or kidney disease), both alone and together. Non-obese diabetic (NOD) mice were used for this study due to their susceptibility to both type 1 diabetes (T1D)- and CVB4-mediated kidney injury, in order to glean a better understanding of how hyperglycemia and viral exposure, when occurring on their own and in combination, may alter the kidneys’ molecular and phenotypic profiles. While no changes in kidney function were observed, molecular biomarkers of kidney injury were significantly up- and downregulated based on T1D and CVB4 exposure, both alone and together, but not in a predictable pattern. By combining individual biomarkers with function and phenotypic measurements (i.e., urinary albumin creatinine ratio, serum creatinine, kidney weight, and body weight), we were able to perform an unbiased separation of injury group based on the type of injury. This study provides evidence that unique kidney injury profiles within a kidney disease health condition are identifiable, and will help us to identify the causes of kidney injury in the future.


  • Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis

    by Ian Ackers, Candice Szymanski, K. Jordan Duckett, Leslie A. Consitt, Mitchell J. Silver, Ramiro Malgor


  • Open Access

    Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases

    by Ian Ackers, Ramiro Malgor

    Chronic diseases account for approximately 45% of all deaths in developed countries and are particularly prevalent in countries with the most sophisticated and robust public health systems. Chronic metabolic diseases, specifically lifestyle-related diseases pertaining to diet and exercise, continue to be difficult to treat clinically. The most prevalent of these chronic metabolic diseases include obesity, diabetes, non-alcoholic fatty liver disease, chronic kidney disease and cardiovascular disease and will be the focus of this review. Wnt proteins are highly conserved glycoproteins best known for their role in development and homeostasis of tissues. Given the importance of Wnt signalling in homeostasis, aberrant Wnt signalling likely regulates metabolic processes and may contribute to the development of chronic metabolic diseases. Expression of Wnt proteins and dysfunctional Wnt signalling has been reported in multiple chronic diseases. It is interesting to speculate about an interrelationship between the Wnt signalling pathways as a potential pathological mechanism in chronic metabolic diseases. The aim of this review is to summarize reported findings on the contrasting roles of Wnt signalling in lifestyle-related chronic metabolic diseases; specifically, the contribution of Wnt signalling to lipid accumulation, fibrosis and chronic low-grade inflammation.


  • Open Access

    Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker

    by Mark Saling, Jordan K. Duckett, Ian Ackers, Karen Coschigano, Scott Jenkinson, Ramiro Malgor

    // <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Mark Saling1, Jordan K. Duckett1, Ian Ackers1, Karen Coschigano1, 2, 3, Scott Jenkinson4 and Ramiro Malgor1, 2, 3 1Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA 2Interdisciplinary Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio, USA 3The Diabetes Institute of Ohio University, Athens, Ohio, USA 4University Medical Associates, Inc., Pathology, Athens, Ohio, USA Correspondence to: Ramiro Malgor, email: malgor@ohio.edu Keywords: urothelial carcinoma, bladder, Wnt5a, epithelial mesenchymal transition, biomarker Received: August 25, 2016 Accepted: February 01, 2017 Published: March 03, 2017 ABSTRACT Bladder cancer is the fourth most common cancer in men and the most common malignancy of the urinary tract. Bladder cancers detected at an early stage have a very high five-year survival rate, but when detected after local metastasis the rate is only about 50%. Our group recently reported a positive correlation between the expression of Wnt5a, a member of the Wnt proteins family, and histopathological grade and stage of urothelial carcinoma (UC). The objective of this study was to analyze UC cases reported in Athens, Ohio and investigate the major components of Wnt5a / planar cell polarity (PCP) signaling pathway in UC human tissue samples and UC cell lines. Formalin fixed and paraffin embedded transurethral resection tissues were immunostained for Wnt5a, Ror-2, CTHRC1 and E-cadherin. In addition, in vitro studies using UC cell lines were investigated for Wnt5a/PCP signaling and epithelial mesenchymal transition (EMT) gene expression. The IHC results showed a correlation between the expression of Wnt5a, Ror2 and CTHRC1 with high histological grade of the tumor, while E-cadherin showed an opposite trend of expression. Real time RT-PCR results showed that RNA expression of the Wnt5a/ PCP pathway genes vary in low and high grade UC cell lines and that the high grade cell lines exhibited signs of EMT. These findings support that Wnt5a-Ror2 signaling plays a role in UC, support the potential use of Wnt5a as a prognostic marker and provide evidence that Wnt5a signaling may be used as an effective molecular target for novel therapeutic tools.


  • Open Access

    Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions

    by Ramiro Malgor, Pooja M. Bhatt, Beth A. Connolly, Denise L. Jacoby, Kyle J. Feldmann, Mitchell J. Silver, Masato Nakazawa, Kelly D. McCall, Douglas J. Goetz

    Objective and design Atherosclerosis (ATH) is a chronic inflammatory disease that involves cascades of signaling events mediated by various effector proteins. Here we sought to determine if the expression of Wnt5a, a secreted glycoprotein, is altered in discrete regions of the arterial plaque. Methods Atherosclerotic plaque tissues from 14 human subjects undergoing elective carotid endarterectomy were used in this study. Immunohistochemistry and laser capture microdissection combined with quantitative real-time PCR were used to determine the expression of Wnt5a and Toll-like receptors (TLRs) in different sections of the arterial lesions. Atherosclerotic serum samples (n = 30) and serum from healthy subjects (n = 16) were quantified for Wnt5a using an enzyme-linked immunosorbent assay (ELISA). Results The data analysis revealed that Wnt5a transcripts and protein were elevated in advanced arterial lesions relative to less advanced arterial lesions; that Wnt5a expression correlated with the presence of TLR4 and TLR2 transcripts; and that the average amount of Wnt5a protein present in atherosclerotic patient serum was significantly higher compared to healthy controls. Conclusions This study is the first to provide evidence that the expression of Wnt5a increases as the disease progresses to a more advanced stage, and that this expression is coincident with that of TLR2 and TLR4. In addition, we found that the average Wnt5a levels in the serum of atherosclerotic patients are elevated relative to healthy controls, which is consistent with the hypothesis that Wnt5a plays a role in ATH.


  • Open Access

    Correlation of Wnt5a expression with histopathological grade/stage in urothelial carcinoma of the bladder

    by Ramiro Malgor, Seth Crouser, Danielle Greco, Colin Brockett, Karen Coschigano, Masato Nakazawa, Scott Jenkinson

    Bladder cancer, including urothelial carcinoma (UC), is the most common malignancy of the urinary tract and the fourth most frequent cancer overall in men. Wnt5a, a member of the Wnt family of proteins, has been shown to have contradictory roles in the pathogenesis of many cancers, acting either as tumor suppressor or tumor promoter. The objective of this study was to investigate the expression and role of Wnt5a in the pathogenesis of UC and suggest possible clinical applications for diagnosis, prognosis and treatment.


    • 1 June 2012
      • Vol. 112  (6) , 374-9

    Coexistence of Cushing syndrome from functional adrenal adenoma and Addison disease from immune-mediated adrenalitis.

    by Randall Colucci, Rafael E Jimenez, William Farrar, Ramiro Malgor, Leonard Kohn, Frank L Schwartz

    A 56-year-old woman presented with an incidental adrenal adenoma and physical examination findings that included moderate obesity, a slight cervicothoracic fat pad ("buffalo hump"), increased supraclavicular fat pads, and white abdominal striae. Biochemical workup revealed elevated levels of 24-hour urinary free cortisol but normal serum morning cortisol and suppressed levels of corticotropin, suggestive of adrenal-dependent Cushing syndrome. The resected adrenal gland revealed macronodular cortical hyperplasia with a dominant nodule. Other findings included an absent cortisol response to corticotropin stimulation, presence of serum anti-21-hydroxylase antibodies, and mononuclear cell infiltration--consistent with adrenalitis. The findings represent, to the authors' knowledge, the first known case of a patient with coexistent functional cortisol-secreting macronodular adrenal tumor resulting in Cushing syndrome and immune-mediated adrenalitis resulting in Addison disease.


  • Open Access

    Toll-Like Receptors as Novel Therapeutic Targets for the Treatment of Pancreatic Cancer

    by Kelly D., Fabian Benencia, Leonard D., Ramiro Malgor, Anthony Schwartz, Frank L.